| index | Title |
| 1 | Tumor immune checkpoints and their associated inhibitors Author(s):Zerui GAO, Xingyi LING, Chengyu SH... Clicked:4176 Download:3645 Cited:0 <Full Text> <PPT> 1620 Journal of Zhejiang University Science B 2022 Vol.23 No.10 P.823-843 DOI:10.1631/jzus.B2200195 |
| 2 | USH2A mutation and specific driver mutation subtypes are associated with clinical efficacy of immune... Author(s):Dexin YANG, Yuqin FENG, Haohua LU,... Clicked:3937 Download:4570 Cited:0 <Full Text> <PPT> 1768 Journal of Zhejiang University Science B 2023 Vol.24 No.2 P.143-156 DOI:10.1631/jzus.B2200292 |
| 3 | Immune checkpoint blockade for cancer therapy: current progress and perspectives Author(s):Hongying YE, Weijie LIAO, Jiongli ... Clicked:3364 Download:6660 Cited:0 <Full Text> <PPT> 906 Journal of Zhejiang University Science B 2025 Vol.26 No.3 P.203-226 DOI:10.1631/jzus.B2300492 |
| 4 | Roles of macrophages in tumor immunotherapy: metabolism, immune checkpoints, and combination strategies Author(s):Shan WANG1,2*Clicked:2288 Download:1780 Cited:0 <Full Text> Journal of Zhejiang University Science B 1998 Vol.-1 No.-1 P. DOI:/10.1631/jzus.B2500179 |